Arcellx (ACLX) Net Margin (2023 - 2025)

Arcellx's (ACLX) quarterly Net Margin came in at 3441.52% in Q4 2025, down 313335.0% year-on-year from N/an in Q4 2024, and down 205.34% quarter-over-quarter from 1127.12% in Q3 2025.

Arcellx (ACLX) Net Margin (2023 - 2025) Analysis & Trends

Arcellx's Net Margin history runs 3 years deep, the most recent figure standing at 3441.52% for Q4 2025.

  • On a quarterly basis, Net Margin fell 313335.0% year-over-year to 3441.52% in Q4 2025; TTM through Dec 2025 was 1023.28%, a 92389.0% decrease from a year earlier, with the FY2025 full-year figure at 1026.86%, down 92740.0% from the prior year.
  • Net Margin fell to 3441.52% in Q4 2025 per ACLX's latest filing, from 1127.12% in the prior quarter.
  • Across five years, Net Margin topped out at 31.42% in Q4 2023 and bottomed at 3441.52% in Q4 2025.
  • The 3-year median for Net Margin is 214.83% (2023), against an average of 592.08%.
  • Across the five-year window, Net Margin soared 16362 bps in 2024 and plunged 313335 bps in 2025, its largest moves.
  • Year by year, Net Margin stood at 31.42% in 2023, then plunged by 1081 bps to 308.17% in 2024, then sank by 1017 bps to 3441.52% in 2025.
  • Per Business Quant, the three latest ACLX Net Margin figures stand at 3441.52% (Q4 2025), 1127.12% (Q3 2025), and 694.36% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - -3,441.52%

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,441.52%
Sep 30, 2025 -1,127.12%
Jun 30, 2025 -694.36%
Mar 31, 2025 -766.02%
Dec 31, 2024 -308.17%
Sep 30, 2024 -99.37%
Jun 30, 2024 -99.19%
Mar 31, 2024 -18.34%
Dec 31, 2023 31.42%
Sep 30, 2023 -262.99%
Jun 30, 2023 -166.66%
Mar 31, 2023 -152.66%